KRAS and non-small cell lung carcinoma: Here, we demonstrate that inhibition of KRAS/PAK1/Crk pathway in conjunction with partial widespread interruption of KRAS signal dramatically alters the morphology, motility and proliferation of KRAS mutant NSCLC cells.